Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3331-3340 of 11775

Edit search filters
  1. Lutetium 177Lu-Edotreotide Versus Best Standard Of Care In Well-differentiated Aggressive Grade-2 And Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE)

    Rochester, MN

  2. PC945 Prophylaxis Or Pre-emptive Therapy Against Pulmonary Aspergillosis In Lung Transplant Recipients

    Jacksonville, FL

  3. Study to Develop a Minimally-Invasive Seizure Gauge

    Rochester, MN

  4. A Study To Evaluate MesilatE For Treating Hospitalized Patients With COVID-19 (Enrolling By Invitation Only)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. A Study To Evaluate The Safety And Tolerability Of Oral Ixazomib In Scleroderma-related Lung Disease Patients

    Scottsdale/Phoenix, AZ

  6. SER-109 Versus Placebo To Prevent Recurrent Clostridium Difficile Infection (RCDI)

    Rochester, MN

  7. Evaluate REC-4881 In Participants With Familial Adenomatous Polyposis (FAP)

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study To Compare Standard Chemotherapy To Therapy With CPX-351 And/or Gilteritinib To To Treat Newly-diagnosed AML With Or Without FLT3 Mutations

    Rochester, MN

  9. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Fruquintinib In Patients With Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

.

Mayo Clinic Footer